123 related articles for article (PubMed ID: 38677015)
1. A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2.
Lu C; Gao H; Li H; Luo N; Fan S; Li X; Deng R; He D; Zhao H
Transl Oncol; 2024 Jul; 45():101962. PubMed ID: 38677015
[TBL] [Abstract][Full Text] [Related]
2. An angiogenesis‑related lncRNA signature for the prognostic prediction of patients with bladder cancer and LINC02321 promotes bladder cancer progression via the VEGFA signaling pathway.
Kang Z; Dou Q; Huang T; Tu M; Zhong Y; Wang M; Li T
Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36579659
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.
Chen L; Liu Z; Tang H; Zhou Z; Chen J; Ma Z; Deng M; Li X; Wu Y; Zheng L; Zhou L; Zheng X; Liu Z
Cell Prolif; 2022 Dec; 55(12):e13325. PubMed ID: 36054300
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Shen C; Wang Y; Wu Z; Da L; Gao S; Xie L; Qie Y; Wang Y; Zhang Z; Tian D; Hu H
Oncol Rep; 2020 Nov; 44(5):1831-1850. PubMed ID: 33000254
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
7. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
[TBL] [Abstract][Full Text] [Related]
9. Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.
Lu S; Guo M; Fan Z; Chen Y; Shi X; Gu C; Yang Y
Am J Transl Res; 2019; 11(7):4397-4410. PubMed ID: 31396344
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.
Xiong T; Huang C; Li J; Yu S; Chen F; Zhang Z; Zhuang C; Li Y; Zhuang C; Huang X; Ye J; Zhang F; Gui Y
J Cancer; 2020; 11(7):1751-1760. PubMed ID: 32194786
[No Abstract] [Full Text] [Related]
11. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer.
Qing L; Gu P; Liu M; Shen J; Liu X; Guang R; Ke K; Huang Z; Lee W; Zhao H
Onco Targets Ther; 2020; 13():12521-12538. PubMed ID: 33324071
[TBL] [Abstract][Full Text] [Related]
13. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
14. High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer.
Qin Z; Wang Y; Tang J; Zhang L; Li R; Xue J; Han P; Wang W; Qin C; Xing Q; Yang J; Zhang W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054424
[TBL] [Abstract][Full Text] [Related]
15. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer.
Yuan H; Qin Y; Zeng B; Feng Y; Li Y; Xiang T; Ren G
Onco Targets Ther; 2019; 12():4883-4895. PubMed ID: 31417284
[TBL] [Abstract][Full Text] [Related]
17. lncRNA
Ma Z; Xue S; Zeng B; Qiu D
Oncol Lett; 2018 Feb; 15(2):1924-1930. PubMed ID: 29434891
[TBL] [Abstract][Full Text] [Related]
18. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/β-catenin and JAK2/STAT3 signaling pathways.
Huang H; Fan X; Zhang X; Xie Y; Ji Z
Transl Androl Urol; 2020 Oct; 9(5):2251-2261. PubMed ID: 33209690
[TBL] [Abstract][Full Text] [Related]
20. SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.
Ke M; Sun N; Lin Z; Zhang P; Hu Y; Wu S; Zheng Z; Lu Y; Jin H
Cancer Cell Int; 2023 Mar; 23(1):48. PubMed ID: 36927398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
